Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
- Published In:
- Journal of autism and developmental disorders, 44(3), 521-31 (2014)
- Authors:
- Dadds, Mark R, MacDonald, Elayne, Cauchi, Avril, Williams, Katrina, Levy, Florence, Brennan, John
- Database ID:
- RPEP-02362
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02362APA
Dadds, Mark R; MacDonald, Elayne; Cauchi, Avril; Williams, Katrina; Levy, Florence; Brennan, John. (2014). Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.. Journal of autism and developmental disorders, 44(3), 521-31. https://doi.org/10.1007/s10803-013-1899-3
MLA
Dadds, Mark R, et al. "Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.." Journal of autism and developmental disorders, 2014. https://doi.org/10.1007/s10803-013-1899-3
RethinkPeptides
RethinkPeptides Research Database. "Nasal oxytocin for social deficits in childhood autism: a ra..." RPEP-02362. Retrieved from https://rethinkpeptides.com/research/dadds-2014-nasal-oxytocin-for-social
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.